Adial Pharmaceuticals, Inc (ADIL) financial statements (2020 and earlier)

Company profile

Business Address 1180 SEMINOLE TRAIL
CHARLOTTESVILLE, VA 22902
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,5303,869
Cash and cash equivalents8,5303,869
Prepaid expense460506
Other undisclosed current assets511318
Total current assets:9,5014,693
Noncurrent Assets
Other noncurrent assets67
Total noncurrent assets:67
TOTAL ASSETS:9,5074,699
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:777258
Accounts payable475 
Accrued liabilities30 
Other undisclosed accounts payable and accrued liabilities272258
Total current liabilities:777258
Noncurrent Liabilities
Total liabilities:777258
Stockholders' equity
Stockholders' equity attributable to parent8,7304,441
Common stock107
Additional paid in capital27,28816,470
Accumulated deficit(18,568)(12,035)
Total stockholders' equity:8,7304,441
TOTAL LIABILITIES AND EQUITY:9,5074,699

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
Gross profit:(186)(1,167)
Operating expenses(7,244)(6,987)
Other undisclosed operating income1861,167
Operating loss:(7,244)(6,987)
Nonoperating expense(558)(4,644)
Interest and debt expense (5)
Loss from continuing operations before equity method investments, income taxes:(7,802)(11,636)
Other undisclosed income from continuing operations before income taxes 5
Net loss available to common stockholders, diluted:(7,802)(11,631)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
Net loss:(7,802)(11,631)
Comprehensive loss, net of tax, attributable to parent:(7,802)(11,631)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: